Biochemical Engineering Special Interest Group
biological engineering professionals
06 September 2016

BioInvent plans 1000L SUB expansionNews

Swedish antibody developer BioInvent is growing its capabilities and has extended a contract with an undisclosed big pharma client. While the firm would not divulge the client's identity, it reported the extension was driven by expansion in antibody production at its facilities in Lund, Sweden. While the quantities produced will depend in the process the firm reports that a new 1000L single-use bioreactor will be capable of producing more than 2Kg of IgG. Source: BiopharmaReporter 6/9/2016

My IChemE

IChemE is a registered charity in England & Wales (214379), and a charity registered in Scotland (SC 039661).